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Abstract: A role for GH and IGF-I in the modulation of the immune system has been under discussion
for decades. Generally, GH is considered a stimulator of innate immune parameters in mammals
and teleost fish. The stimulatory effects in humans as well as in bony fish often appear to be
correlated with elevated endocrine IGF-I (liver-derived), which has also been shown to be suppressed
during infection in some studies. Nevertheless, data are still fragmentary. Some studies point to an
important role of GH and IGF-I particularly during immune organ development and constitution.
Even less is known about the potential relevance of local (autocrine/paracrine) IGF-I within adult
and developing immune organs, and the distinct localization of IGF-I in immune cells and tissues of
mammals and fish has not been systematically defined. Thus far, IGF-I has been localized in different
mammalian immune cell types, particularly macrophages and granulocytes, and in supporting cells,
but not in T-lymphocytes. In the present study, we detected IGF-I in phagocytic cells isolated from
rainbow trout head kidney and, in contrast to some findings in mammals, in T-cells of a channel
catfish cell line. Thus, although numerous analogies among mammals and teleosts exist not only for
the GH/IGF-system, but also for the immune system, there are differences that should be further
investigated. For instance, it is unclear whether the primarily reported role of GH/IGF-I in the innate
immune response is due to the lack of studies focusing on the adaptive immune system, or whether
it truly preferentially concerns innate immune parameters. Infectious challenges in combination with
GH/IGF-I manipulations are another important topic that has not been sufficiently addressed to date,
particularly with respect to developmental and environmental influences on fish growth and health.
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1. Introduction: The GH/IGF-System and the Immune System
In mammals and in bony fish, a role for the growth hormone (GH)/insulin-like growth factor
(IGF)-system in the modulation of the immune system has been under debate for decades. In general,
GH is considered a stimulator of the immune system in mammals [1–4] as well as in bony fish [5,6].
Generally, IGF-I is a potent growth factor that stimulates immune cell growth and differentiation and
inhibits apoptosis [1,3].
In mammals and fish, (endocrine) IGF-I is mainly produced in the liver, with GH being the
major stimulus for its synthesis and release into the circulation. There is general agreement that
the serum IGF-I concentration influences GH release from the anterior pituitary via a negative
feedback mechanism by specific inhibition of GH gene transcription and secretion in mammals [7–9]
and teleosts [10–14]. While the GH/IGF-I axis is generally considered well-preserved throughout
phylogeny [13–16], the role of IGF-II is still enigmatic in fish [11,15]. Furthermore, in bony fish a
few years ago, a third IGF (IGF-3) has been postulated to be expressed exclusively in gonads [17].
In tilapia, IGF-3 expression was also detected by real-time PCR in other tissues including head kidney
and spleen, but to a much lower extent than in the gonads [18]. The GH/IGF-system of bony fish
further consists of multiple subtypes of GH receptors (GHR), IGF receptors and IGF binding proteins
that arose through gene duplication events, which occurred during evolution of the teleost lineage
(for further reading, see [19]).
In this review, we will mainly focus on the GH/IGF-I axis, particularly since most published data
in the context of the fish (and mammalian) immune system concern the axis GH-GHR-IGF-I with some
comparative aspects on mammals at the end of the respective chapters.
2. GH and IGF-I Actions in Bony Fish Immune Responses
Indications exist that IGF-I plays important roles in cell proliferation, differentiation and
functional modulation of the immune system of fish [5,6,20,21]. Studies so far have shown that
in the piscine immune system, exogenous administration of GH enhanced innate immune activities of
leukocytes [22] and phagocytes [23] and activated rainbow trout and gilthead sea bream phagocytes
in vitro [24] and in vivo [25,26]. Furthermore, GH stimulated the respiratory burst of leukocytes in
vibriosis-furunculosis-vaccinated rainbow trout [27] and the plasma lysozyme activity, which is a
marker for the innate immune system, in rainbow trout and channel catfish [20,28]. Further, both
GH and IGF-I stimulated the proliferation of gilthead sea bream head kidney leukocytes in vitro [21].
Thus far in two different fish species, GH treatment was combined with bacterial infection: in rainbow
trout challenged with Vibrio anguillarum, the bactericidal activity was not enhanced by GH [26].
In another study in channel catfish infected with Edwardsiella ictaluri, the mortality was not positively
influenced [28]. Nevertheless, the immune systems of these species investigated so far, strongly differ
from each other, not only due to their different environments, which is cold water for rainbow trout
and warm water for channel catfish. Thus, more studies considering different life traits, environments
and pathogens are needed to gain further insights why positive influences of GH on different immune
functions may not lead to an efficient immune response and an improved health status.
Innate immune functions are stimulated also by IGF-I: in vitro administration of salmon IGF-I,
human IGF-I, and IGF-II increased superoxide production in zymosan-stimulated rainbow trout head
kidney leukocytes, and salmon IGF-I had a significant effect on superoxide production, which was
observed to be equipotent to that of salmon GH [29]. Two IGF type-I receptors (IGFR Ia and IGFR
Ib) and GHR1 and GHR2 genes were detected in brain, pituitary, liver, and gills, as well as in head
kidney leukocytes, except IGFR Ia gene expression was absent in head kidney leukocytes. In the same
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study, in vivo intraperitoneal injection of salmon IGF-I increased the plasma levels of lysozymes [29].
In summary, these data mainly point to the stimulation of innate immune reactions including cell
expansion, particularly of phagocytes by both, GH and IGF-I.
Although, admittedly, the majority of published reports examined only innate immune parameters
and did not consider adaptive immune parameters, it remains an open question whether the
immune-modulating action of GH/IGF-I in fish indeed is restricted to the innate system or whether
this current state of knowledge is due to an unbalanced data basis.
Thus far, only fragmentary data regarding the relevance of endocrine IGF-I (IGF-I serum levels)
and/or paracrine/autocrine actions exists. The importance of systemic GH and IGF-I in the immune
competence of fish, respectively, has been observed in the above mentioned channel catfish challenged
with Edwardsiella ictaluri [28]. Here, lower IGF-I serum levels and down-regulated hepatic GHR
expression were found. While treatment with recombinant bovine GH increased lysozyme activity,
it did not elevate the IGF-I serum levels and GHR expression as compared to the control fish, which
the authors attributed to the dietary regimen of this study. In addition, Bilodeau et al. [30] reported
reduced mean plasma IGF-I levels in juvenile hybrid catfish after challenge with Edwardsiella ictaluri.
In light of the general importance of IGF-I during fish growth and organ development
(e.g., [18,31]), not much is known on its role during development of the immune system. Thus,
further studies should enlighten the potential interactions between GH/IGF and the immune systems,
particularly during development.
First reports in human patients also point to a potential relevance of systemic IGF-I in immune
competence: children who did not survive a septic shock possessed lower IGF-I serum levels than the
survivors [32]. Furthermore, children during sepsis and septic shock also showed a suppression of
IGF-I serum levels [33]. In both studies, high GH serum levels were measured, which were attributed
to a stimulated GH release via the above mentioned feed-back mechanism or to increased endotoxin
and cytokine load, respectively [32–34]. Furthermore, in HIV-infected patients, the IGF-I serum level
gain was found to be a critical marker of the efficiency of GH treatment for the restoration of CD4+ T
helper cells [35].
Thus, systemic elevation of GH and/or IGF-I levels seems to play a crucial role in the immune
response of mammals and this may apply for bony fish as well as indicated from the few studies
published so far.
However, local effects may exist that have not been sufficiently studied to date. Better knowledge
in this field is necessary with respect to the increasing detection of the presence of hormones,
their receptors and releasing hormones in immune cells themselves. This local presence of hormone
systems within the immune system has recently been reviewed by Csaba [36], who highlighted the fact,
that immune cells synthesize, store and secrete hormones identical to those of the endocrine glands,
for example:
‚ pro-opio-melanocortin hormones;
‚ thyroid system hormones;
‚ GH and prolactin;
‚ melatonin, histamine, serotonin and catecholamines;
‚ gonadotropin-releasing hormones; and
‚ their respective receptors.
Both GH and prolactin, in addition to erythropoietin [37] and leptin, have been classified amongst
the short-chain cytokines of the type 1 cytokine family, which supports the dual role of GH as a
hormone and a cytokine (for further reading, see [38]).
In his review, Csaba [36] points out that the immune cells may be similar to the unicells
(Tetrahymena), and thus retain the characteristics of this early phylogenetic level, while other cells
during evolution accumulated together to form endocrine glands. As mobile cells, immune cells
are able to transport the stored hormone to different locations (packed transport) or when attracted
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by local factors, accumulate in the region of the target, to synthesize and secrete hormones locally.
The targeted packed transport is more economical than the hormone-release into the blood circulation
by glandular endocrine organs.
However, while the distinct localization of IGF-I has been studied for many endocrine glands in
mammals (e.g., [7,8,15]), as well as in fish (e.g., [13–16,31,39]), in the immune system, particularly in
fish, it has not been systematically explored to date.
3. Immune Cells of Fish as Site of Local IGF Synthesis
Initial studies have detected IGF-I gene expression in immune organs of teleost fish and even
found some correlation with infection or stress. However, the distinct localization at the cellular level
has not been investigated in bony fish to date. Particularly since the head kidney is anatomically located
nearby the excretory kidney, it has to be considered that it possesses a complex cellular composition.
Different cell types express IGF-I as reported in tilapia, e.g., the cells of the Oreochromis niloticus renal
tubules [31], or the Oreochromis mossambicus interrenal cells [40].
In addition, in the gilthead sea bream Sparus aurata and the rainbow trout Oncorhynchus mykiss,
IGF-I gene was expressed in head kidney [41–44]. In situ hybridization of the tilapia head kidney
revealed IGF-I mRNA in numerous immune cells [42,43,45]. In kidney and spleen of male and female
yellow perch (Perca flavescens), a moderate expression of both IGF-I amplification products, IGF-Ia
and IGF-Ib was detected [46]. The expression of both, IGF-I and IGF-II genes, has been described in
adult tilapia spleen [42,43,45,47], gilthead sea bream and tilapia head kidney [41–43]. In red-banded
sea bream head kidney and spleen, the expression levels were much lower for IGF-I than for IGF-II,
which were similar to IGF-II expression levels in liver [48].
In order to further elucidate the distinct localization of IGF-I in leukocytes and to evaluate
whether there exist analogies between higher and lower vertebrates, we investigated the presence of
IGF-I in different leukocytes. For the detection of IGF-I mRNA (Figure 1a) and peptide (Figure 1b),
we used T-cells from a defined Channel catfish (Ictalurus punctatus) T-cell line G14D established by
Norman Miller, University of Mississippi Medical Center, Jackson, MS and co-workers [49]. Cells were
purchased from ATCC (Cat.No: CRL-2759, [49]) and cultured according to protocol [50] in incomplete
channel catfish medium supplemented with channel catfish serum kindly provided by Professor
Miller. For real-time PCR (Figure 1a), primers and probes were created based on mRNA sequences
of I. punctatus IGF-I (GenBank Access No: NM_001200295.1 [51]), and O. mossambicus 18S rRNA
(GenBank Access No: AF497908.1) and obtained from Microsynth as described for other species and
tissues (e.g., [42,43,47,52,53]). For immunocytochemistry (Figure 1b), cells from the same T-cell line
G14D were fixed and by cytospin transferred to slides for immunostaining as described previously [54]
using antiserum against IGF-I as described [31,55].
In order to investigate another fish species important in local aquaculture, we further detected
IGF-I in head kidney leukocytes (Figure 1c) freshly isolated from adult female rainbow trout
(Oncorhynchus mykiss) reared at the facilities of the Institute for Fish and Wildlife Health, University
of Bern as described elsewhere [54]. In brief, the fish were kept under flow-through conditions
(0.5 L/min) in air-saturated tap water (temperature 15 ˘ 1 ˝C). The head kidney leukocytes were
characterized by an immunocytochemistry protocol [54] using a myeloid lineage marker specific
monoclonal antibody [56], which recognizes a cell surface marker expressed on rainbow trout immune
leukocytes ranging from immature myeloblasts to phagocyting cells, which are capable of respiratory
burst. Thus, it can be considered as a common lineage marker for the myeloid lineage [56].
While IGF-I could be detected in T-cells from both fish species investigated, in contrast, in mature
mammalian T-cells, intracellular IGF-I has not been detected to date (e.g., in the thymus, IGF-I was
not found in T-cells and local IGF-I supply seems to be derived from thymus epithelial cells [57]).
Nevertheless, its role in mammalian T-cell development appears to be pronounced (e.g., [58]).
Most recently, in humans, we described the local presence of IGF-I in neutrophils of the tumor
microenvironment of a lymphoma [59], which to the best of our knowledge was the first detection of
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IGF-I in granulocytes. Since we proposed an important role for IGF-I in cell shaping and restitution,
e.g., of the high endothelial venules of human lymph nodes, we assume that IGF-I in phagocytic cells
might be involved in cell growth, repair and proliferation, particularly of phagocytes. The production
and/or local presence of IGF-I in macrophages have been previously demonstrated for humans and
mice (e.g., [60,61]).Biology 2016, 5, 9 5 of 12 
 
Figure 1. Detection of IGF-I in channel catfish (I. punctatus) and rainbow trout (O. mykiss) leukocytes. 
(a,b) IGF-I mRNA and peptide in I. punctatus T-cell line G14D using (a) PCR and (b) 
immunocytochemistry. (a) Agarose gels of real-time PCR products confirming the presence of IGF-I 
mRNA (bands 2–4) at the expected size (73 bp) and reference gene 18S rRNA (bands 5–6) at the 
expected size (85 bp). Bands 1 and 7: molecular weight marker. (b) The majority of the T-cells show 
IGF-I immunoreactive material (brown color) within the cytoplasm. Nuclei counterstained with 
haematoxylin. Bar: 60 µm. (c) Head kidney leukocytes freshly isolated from rainbow trout were 
adjusted to 1 × 107 cells/mL, incubated with mouse mAb against rainbow trout granulocytes 
(mAbQ4E; [56]) visualized with a Texas red-coupled anti-mouse antibody as previously described 
[54]. Subsequently, cells were fixed for intracellular labeling for IGF-I using the same antiserum as in 
(b) followed by a FITC-coupled anti rabbit antibody for double immunofluorescence of IGF-I (green) 
in phagocytic cells (red, arrow). Note the small cells immunoreactive for IGF-I, which do not express 
the granulocyte marker (single arrowheads) and the large cell immunoreactive for the granulocyte 
marker, but without immunoreactivity for IGF-I (double arrow heads). Bar: 30 µm. 
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gilthead sea bream [71] and in sea bass by immunohistochemistry in immune cells, which were 
morphologically identified from head kidney smears [21]. Here, aside from the different precursors 
of the erythropoietic line, also members of the myelocytic line exhibited GH binding capacity, 
particularly prominent in myeloblasts and to an appreciable extent in myelocytes. While mature 
eosinophils did not show binding of GH, immature eosinophils were labeled mainly at the 
periphery. A light binding was also observed in immature neutrophils while basophils were not 
detected on the smears which can be explained by their similar scarcity as in humans. 
Monocytes/macrophages which were very sparsely detectable, exhibited a faintly positive reaction 
for GH binding. Large and small lymphocytes also showed appreciable staining while no binding 
was detected in thrombocytes [21], which have been recently demonstrated to be capable of acting as 
phagocytic immune cells in teleost fish [72]. Interestingly, in rainbow trout, erythroid cells and also a 
subpopulation of B-lymphocytes responded to erythropoietin, while granulocytes and thrombocytes 
did not [37]. Thus, more studies are needed on stimuli of immune cell lineage differentiation and 
proliferation. 
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can be explained by their similar scarcity as in humans. Monocytes/macrophages which were very
sparsely detectable, exhibited a faintly positive reaction for GH binding. Large and small lymphocytes
also showed appreciable staining while no binding was detected in thrombocytes [21], which have
been recently demonstrated to be capable of acting as phagocytic immune cells in teleost fish [72].
Interestingly, in rainbow trout, erythroid cells and also a subpopulation of B-lymphocytes responded
to erythropoietin, while granulocytes and thrombocytes did not [37]. Thus, more studies are needed
on stimuli of immune cell lineage differentiation and proliferation.
In rainbow trout spleen, the IGF-I steady-state levels were unaffected by GH treatment and only
increased over time [66]. In the tilapia O. niloticus, GH injections increased IGF-I mRNA in the head
kidney, even more than in the liver, which is the main source of endocrine IGF-I. This elevation in
the head kidney could be morphologically verified by in situ hybridization. Here again, IGF-I mRNA
could be localized in numerous immune cells. IGF-II and GHR gene expressions were not affected
by GH treatment [43]. In the spleen, also no change occurred in GHR mRNA, but both, IGF-I and
IGF-II mRNAs were increased as could be localized by in situ hybridization where IGF-I mRNA was
increased in immune cells.
However, the immunological potential of local IGF-I and potential stimulation by GH treatment
remains to be investigated. Thus far, in the head kidney of Enteromyxum leei-infected gilthead sea
bream (Sparus aurata), IGF-I gene expression declined, which was accompanied by a down-regulation
also of the GHR expression. In contrast, the non-infected individuals showed increased IGF-I and
GHR expression levels. From these results, the authors concluded that an increase in IGF-I and GHR
expression might be advantageous for immune cells in response to the parasite [41].
The role of autocrine/paracrine IGF-I as related to endocrine IGF-I is also not that clear to
date [53,73], and even less is known with respect to fish health. Disturbances of fish health, e.g., by stress
and infection, might alter the GH/IGF-I axis at different levels and, thus, impact fish growth, however
potential interactions among stress, health and growth are generally extremely complex and not
much is known thus far as summarized by Beckman [73]. Thus far, in sea bream during vibriosis
infection, the local IGF-I gene expression in liver and kidney was down-regulated [74], but whether
this may be due to the general stress situation of the organism or to alterations of the GH/IGF-I axis or
specifically induced by the infection remains to be clarified. For instance, also in gilthead sea bream
exposed to confinement stress, IGF-I gene expression was declined in the liver [75] and rearing and
handling conditions as well as many other factors impact the complex fish physiology, in particular
the GH/IGF-I axis [73].
A potential crosstalk between IGF-I and other growth factors and cytokines is coming into focus
for research in mammals (e.g., [76]), and this might be of particular interest also for fish research.
As mentioned above, human and murine myeloid cells, particularly macrophages, produce
IGF-I in relatively large amounts [60,61], also stimulated by cytokines such as tumor necrosis factor
(TNF)-α [77,78], which was also reported to induce a state of resistance against IGF-I [79]. Vice versa,
there exist indications that IGF-I counteracted sickness behavior and depression in mice induced by
cytokines including TNF-α [80]. However, data are rudimentary and even contradictory: in GH-treated
growth-deficient children altered metabolic parameters including TNF-α levels are reported e.g., [81],
and modulation of cytokines by GH at high doses is suggested to be involved in adverse consequences
in critically ill patients, such as septic shock and uncontrolled infections [82].
Thus, the idea of a bidirectional communication between neuroendocrine and immune system
exists and demands a search for better knowledge also in fish [38]. While different cytokines have
already been explored in fish (for reviews, see [83,84]), data on potential interactions with the GH/IGF-I
axis are still very fragmentary and mainly deal with TNF-α: e.g., in GH-injected tilapia, TNF-α
expression was elevated in the liver [43] and in a GH-RH-treated flounder embryonic cell line, TNF-α
mRNA was also induced, while in a primary pituitary cell culture, TNF-α mRNA was decreased [85].
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5. IGF-I and TNF-α during Pathogenic Infection of Fish
A possible role of IGF-I and TNF-α in infection and the capability of the host to cope with tissue
damage has been previously demonstrated by treating developing rainbow trout, prior to infection
with Yersinia ruckeri, with 17β-estradiol (E2). The effects of either E2-treatment or the bacterial infection
or combination of both on the expression pattern of cytokines (i.e., TNF-α) and/or growth factors
(i.e., IGF-I) was tissue and treatment specific [44]. The results indicate a stimulatory effect of infection
on IGF-I and TNF-α gene expression in the spleen: IGF-I was elevated 6.802-fold (p = 0.0001) at Day 3
after infection with 106 colony-forming unit (CFU) of Yersinia ruckeri [86,87] and TNF-α gene expression
60.497-fold (p = 0.001) as compared with the uninfected control [44]. The infection reduced the survival
rates of the rainbow trout to 61% [87]. In contrast, in the head kidney, three days after infection both,
IGF-I and TNF-α were lowered, IGF-I to 0.093-fold (p = 0.0001), and TNF-α to 0.079-fold (p = 0.0001),
respectively. IGF-I and TNF-α gene expressions were lower also prior to infection already after the
developmental E2-treatment. Both treatments induced additive effects [44].
There exists evidence for interactions between the reproductive state and fish health, particularly
the immune system (reviewed by [5,14,38,88]). The suppression of IGF-I by E2 in head kidney was
consistent with previous findings by our group where IGF-I was still lower even 1 month after
termination of the estrogen treatment [42]. Interestingly, both IGF-I and TNF-α reacted in parallel
to both stimuli, E2 treatment and infection [44]. In addition, after E2-treatment of juvenile sea bass
(Dicentrarchus labrax), suppressed TNF-α gene expression in head kidney leukocytes was reported [89].
In the spleen, we observed a stimulatory effect of infection with Yersinia on both, IGF-I and
TNF-α gene expressions with a dose-dependent increase in the E2-treated groups. Particularly TNF-α
expression levels were massively elevated by the infection (60.497-fold in the group without E2
pre-treatment, 322.568-fold in the low E2 pre-treatment, 5651.008-fold in the high E2 pre-treatment
group) [44]. However, the lack of response of IGF-I gene expression to estrogen treatment was different
from previous findings by our group where IGF-I was strongly suppressed even one month after
cessation of treatment [42].
In conclusion, the results of the study point to tissue specific effects of either treatment. While in
liver and head kidney, the effects were suppressive on both, IGF-I and TNF-α expression levels,
in spleen, the gene expression levels were stimulated. Thus, the proposed high TNF-α expression as
an indicator for the degree of infection in rainbow trout in another study [90] may be counteracted by
the spleen with a parallel elevation of IGF-I, although to a lesser extent. This local elevation of IGF-I
as described [44] may be supportive for survival in fish as previously suggested by other studies in
humans and fish. Further studies are needed to explore the complex interactions between cytokines
and growth factors (for reviews on research in fish see, e.g., [5,6,10,12,38,83,91]).
6. Conclusions
Numerous indications derived from studies in different fish species point to interactions between
the GH/IGF and the immune system. Although most data support the current assumption of a general
stimulatory action of GH and IGF-I on immune cell expansion and functional parameters, it remains
an open question whether the immune-modulating action of GH/IGF-I in fish indeed is restricted to
the innate system or whether this is due to the thus far available data basis. Our detection of IGF-I in
channel catfish T-lymphocytes points to a role also in the adaptive immune system.
More studies are required to take into consideration different life traits, environments,
and pathogens in order to better compare species differences. In particular, studies are needed
to investigate why positive influences of GH on different immune functions do not generally lead
to an efficient immune response and an improved health status. A better understanding of this
phenomenon may be revealed by research into the role of the GH/IGF-I axis during development
of fish immune organs and cell subtypes. Here too, more tools to characterize cell lineages and the
increasing number of cytokines detected in bony fish will also contribute to a better understanding of
the complex orchestration of cytokines and growth factors in the fish immune system.
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